Login / Signup

Once-daily rabeprazole, levofloxacin, clarithromycin-MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study).

Jeerayuth AuttajaroonRatha-Korn VilaichonePeranart ChotivitayatarakornVarocha Mahachai
Published in: Helicobacter (2019)
The once-daily 14-day rabeprazole-, levofloxacin-, clarithromycin-MR-, and bismuth-containing therapy provided high eradication rate suggested that triple therapies with a PPI, bismuth, and clarithromycin-MR or levofloxacin would be highly effective for once-a-day tailored therapy or as empiric therapy for first-line regimen.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • contrast enhanced
  • magnetic resonance
  • physical activity
  • visible light
  • magnetic resonance imaging
  • stem cells
  • smoking cessation
  • replacement therapy